www.klahnlab.de, ORCID 0000-0003-4713-2345
Anna K. H. Hirsch (HZI/HIPS, Germany)
Stephan A. Sieber (TU München, Germany)
Annelise E. Barron (Stanford University, USA)
Anders Karlén (Uppsala University, Sweden)
Kim Lewis (Northeastern University, USA, online)
Paul J. Hergenrother (University of Illinois Urbana-Champaign, USA)
Anna K. H. Hirsch (HZI/HIPS, Germany)
Stephan A. Sieber (TU München, Germany)
Annelise E. Barron (Stanford University, USA)
Anders Karlén (Uppsala University, Sweden)
Kim Lewis (Northeastern University, USA, online)
Paul J. Hergenrother (University of Illinois Urbana-Champaign, USA)
#MasterThesis #GenderEquality #DrugDevelopment #ClinicalTrials #HealthTech
#MasterThesis #GenderEquality #DrugDevelopment #ClinicalTrials #HealthTech
- Real-world impact & collaboration with industry
- Flexible scope (30 or 60 ECTS)
- Skills in research, data analysis & scientific writing
- Real-world impact & collaboration with industry
- Flexible scope (30 or 60 ECTS)
- Skills in research, data analysis & scientific writing
- Gender equality in drug development today
- Barriers women face in clinical studies
- Data-driven solutions to create safer, more inclusive medicines
- Gender equality in drug development today
- Barriers women face in clinical studies
- Data-driven solutions to create safer, more inclusive medicines
Anna K. H. Hirsch, @helmholtzhzi.bsky.social
Stephan Sieber, @sieberlab.bsky.social, @tum.de
Annelise E. Barron, Stanford University
Anders Karlén, Uppsala University
Kim Lewis, Northeastern University
Paul Hergenrother, University of Illinois Urbana-Champaign
Anna K. H. Hirsch, @helmholtzhzi.bsky.social
Stephan Sieber, @sieberlab.bsky.social, @tum.de
Annelise E. Barron, Stanford University
Anders Karlén, Uppsala University
Kim Lewis, Northeastern University
Paul Hergenrother, University of Illinois Urbana-Champaign